Volume 11, 2007 Articles |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Information Resources and Software for the Hospital Compounding Pharmacist
McElhiney Linda F
|
Jan/Feb 2007
Pg. 36-41
|
Psychotropic Medications in the Treatment of Feline Urine Spraying
Simpson Barbara Sherman, Vail Jane
|
Jan/Feb 2007
Pg. 44-48
|
Basics of Compounding for Hazardous Drugs, Part 3: Safe Handling and Personal Protection
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 50-51
|
PreScription: IJPC: The Next 10 Years
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 2
|
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1
Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
|
Jan/Feb 2007
Pg. 5-8
|
Principles of Pediatric Palliative Care and Pain Control
Peralta Alexander Jr
|
Jan/Feb 2007
Pg. 10-15
|
Pediatric Oral Formulations: A Continual Challenge
Hurtado Josephine, Moffett Brady S
|
Jan/Feb 2007
Pg. 17-19
|
Sevelamer Suspension in Children with End-Stage Renal Disease
McElhiney Linda F
|
Jan/Feb 2007
Pg. 20-24
|
Case Report: Cocktail Dosing in a Premature Infant with a History of Cholestasis
Fields Shannon W
|
Jan/Feb 2007
Pg. 26-27
|
Case Report: Treatment of Labial Adhesions in a Child
Fields Shannon W
|
Jan/Feb 2007
Pg. 27
|
Compounding In Crisis:The Aftermath of Hurricane Katrina
Vail Jane
|
Jan/Feb 2007
Pg. 28-35
|
Quality Control Analytical Methods: The Quality of Sterility Testing
McGuire Jason, Kupiec Thomas C
|
Jan/Feb 2007
Pg. 52-55
|
Collaborative Drug Therapy Management and its Application to Pharmaceutical Compounding
Anderson Derick
|
Jan/Feb 2007
Pg. 56-58
|
Pharmacogenomics: The End of Trial-and-Error Medicine?
Vail Jane
|
Jan/Feb 2007
Pg. 59-65
|
Standard Operating Procedure: Refrigerator—Installation,Maintenance, Cleaning, and Power Interruptions
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 66-67
|
Calculations
Stockton Shelly J
|
Jan/Feb 2007
Pg. 68
|
Caffeine Citrate 10-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 69
|
Carbidopa 1.25-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 70
|
Clonidine Hydrochloride 0.1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 71
|
Dexamethasone 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 72
|
Fluoxetine Hydrochloride 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 73
|
Lansoprazole 3-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 74
|
Methyldopa 25-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 75
|
Metolazone 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 76
|
Prednisone 10-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 77
|
Prednisolone Sodium Phosphate 10-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 78
|
Chemical Stability of Desonide in Ear Drops
Gupta Vishnu D
|
Jan/Feb 2007
Pg. 79-81
|
Physical and Chemical Stability of Palonosetron with Metoclopramide and Promethazine During Simulated Y-Site Administration
Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
|
Jan/Feb 2007
Pg. 82-85
|
PostScription: IJPC—More Than a Journal
|
Jan/Feb 2007
Pg. 88
|
PreScription: Putting the Science Back into Pharmacy
Allen Loyd V Jr
|
Mar/Apr 2007
Pg. 92
|
Insulins: Historical and Current Perspectives
Vance Dwight A
|
Mar/Apr 2007
Pg. 95-104
|
Compounding for the Complications of Diabetes: Interviews with Compounding Pharmacists George B. Muller, RPh, and Jerrod Roberts, DPh
Vail Jane
|
Mar/Apr 2007
Pg. 106-110
|
Certified Diabetes Educator: A Credential for Compounding Pharmacists
Allen Loyd V Jr
|
Mar/Apr 2007
Pg. 113-115
|
Challenges of Compounding for Patients on the Ketogenic Diet
McElhiney Linda F
|
Mar/Apr 2007
Pg. 116-120
|
Compounded Treatments for Erectile Dysfunction: A Common Complication of Diabetes
Fields Shannon W
|
Mar/Apr 2007
Pg. 122-124
|
Calculations
Stockton Shelly J
|
Mar/Apr 2007
Pg. 152
|
Standard Operating Procedure: Discarding of Broken Glass
Allen Loyd V Jr
|
Mar/Apr 2007
Pg. 153
|
Aspirin 80-mg/5-mL Oral Liquid, Anhydrous
Allen Loyd V Jr
|
Mar/Apr 2007
Pg. 154
|
Including Pets in Diabetic Care
Davidson Gigi S
|
Mar/Apr 2007
Pg. 126-130
|
Case Report: Shingles Triple Cream in the Treatment of Herpes Zoster
Fields Shannon W
|
Mar/Apr 2007
Pg. 131
|
Records and Record-Keeping for the Hospital Compounding Pharmacist
McElhiney Linda F
|
Mar/Apr 2007
Pg. 138-143
|
Quality Control Analytical Methods: Considerations in Compounding Peroral Solid Dosage Forms
Vu Nicole
|
Mar/Apr 2007
Pg. 145-148
|
Basics of Compounding for Hazardous Drugs, Part 4: Developing the Hazardous Drugs List and Containment Workstations
Allen Loyd V Jr
|
Mar/Apr 2007
Pg. 149-151
|
Busulfan 2-mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2007
Pg. 155
|
Cefuroxime Axetil 10-mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2007
Pg. 156
|
Metformin Hydrochloride 100-mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2007
Pg. 157
|
Ondansetron Hydrochloride 0.8mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2007
Pg. 158
|
Innovative Uses of Compounded Tranilast: An Interview with Compounding Pharmacist Larry J. Frieders, RPh
Vail Jane
|
Mar/Apr 2007
Pg. 132-135
|
Oral Liquid Vehicle, Anhydrous
Allen Loyd V Jr
|
Mar/Apr 2007
Pg. 159
|
Phenoxybenzamine Hydrochloride 2-mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2007
Pg. 160
|
Ranitidine Hydrochloride 15-mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2007
Pg. 161
|
Tegaserod Meleate 0.1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2007
Pg. 162
|
Triprolidine Hydrochloride 0.25-mg/mL Syrup
Allen Loyd V Jr
|
Mar/Apr 2007
Pg. 163
|
Stability of Oseltamivir in Various Extemporaneous Liquid Preparations
Ford Stephen M, Kloesel Lawson G, Grabenstein John D
|
Mar/Apr 2007
Pg. 164-176
|
PostScription: Responsibility: A Critical Aspect of Compounding Pharmacy
Roberts Jerrod
|
Mar/Apr 2007
Pg. 178
|
Levorphanol for Excruciating Pain from Oral Cancer: A Case Report
McNulty Jack P
|
May/Jun 2007
Pg. 212-218
|
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2
Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
|
May/Jun 2007
Pg. 220-225
|
Basics of Compounding for the Implementation of United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 1
Allen Loyd V Jr, Okeke Claudia C
|
May/Jun 2007
Pg. 230-236
|
Calculations - Compounding for Pain Management
Stockton Shelly J
|
May/Jun 2007
Pg. 238-239
|
Standard Operating Procedure: Basic Compounding Documentation--the Master Formula Form
Allen Loyd V Jr
|
May/Jun 2007
Pg. 240-241
|
Benazepril 2-mg/mL Oral Liquid
Allen Loyd V Jr
|
May/Jun 2007
Pg. 242
|
Cholecalciferol 40,000-IU/mL Oral Liquid
Allen Loyd V Jr
|
May/Jun 2007
Pg. 243
|
Folic Acid 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
May/Jun 2007
Pg. 244
|
Glycopyrrolate 0.5-mg/mL Oral Liquid
Allen Loyd V Jr
|
May/Jun 2007
Pg. 245
|
Isoproterenol Compound Elixir
Allen Loyd V Jr
|
May/Jun 2007
Pg. 246
|
Levothyroxine Sodium 40-micro-g/mL Oral Liquid
Allen Loyd V Jr
|
May/Jun 2007
Pg. 247
|
Losartan Potassium 2.5-mg/mL Oral Liquid
Allen Loyd V Jr
|
May/Jun 2007
Pg. 248
|
Methylphenidate 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
May/Jun 2007
Pg. 249
|
Thiamine Hydrochloride 100-mg/mL Oral Liquid
Allen Loyd V Jr
|
May/Jun 2007
Pg. 250
|
Trovafloxacin Mesylate 10-mg/mL Oral Liquid
Allen Loyd V Jr
|
May/Jun 2007
Pg. 251
|
Rheologic Profile, Specific Gravity, Surface Tension, and pH of Fifteen Over-the-Counter Preparations
Al-Achi Antoine, Baghat Tushar, Chukwubeze Onah, Dembla Ishwin
|
May/Jun 2007
Pg. 252-258
|
Chemical Stability of Hydrocortisone in an Oral Liquid Dosage Form without Suspending Agents
Gupta Vishnu D
|
May/Jun 2007
Pg. 259-261
|
PostScription: Lobbying: How It Affects Compounding
Rock Jim
|
May/Jun 2007
Pg. 262-263
|
PreScription: State or Federal Control of Pharmacy Practice
Allen Loyd V Jr
|
May/Jun 2007
Pg. 178
|
Transdermal Gel in the Treatment of Postoperative Pain
Alexander Kayla, Wynn Tom
|
May/Jun 2007
Pg. 181-184
|
Oral Methadone for Management of Regional Sympathetic Dystrophy Syndrome: A Case Revisited
Vail Jane
|
May/Jun 2007
Pg. 187-192
|
The Rectal Rocket: A Two-Day Treatment for Hemorrhoids
Vail Jane
|
May/Jun 2007
Pg. 194-199
|
Case Report: Ketoprofen/Riboflavin/Caffeine Capsules and Progesterone Therapy for Recurrent Migraine Pain
Fields Shannon W
|
May/Jun 2007
Pg. 200
|
Levorphanol for the Treatment of Severe Chronic Pain
McNulty Jack P
|
May/Jun 2007
Pg. 202-211
|
Quality Control: Standard Operating Procedures--An Essential Tool for Developing Quality Preparations
Ashworth Lisa D
|
May/Jun 2007
Pg. 226-229
|
PreScription: Bias, NAMS, and HRT
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 266
|
Correcting Misconceptions about Compounding Bioidentical Hormones: A Review of the Literature
Paoletti Jim, Kaul Monica, Kloesel Lawson G
|
Jul/Aug 2007
Pg. 269-272
|
The History of Progesterone
Newton Stephen J
|
Jul/Aug 2007
Pg. 274-277
|
Premarin: The Intriguing History of a Controversial Drug
Vance Dwight A
|
Jul/Aug 2007
Pg. 282-286
|
Common Acronyms Used by Health Professionals Who Prescribe or Prepare Hormone Replacement
Price Dared L
|
Jul/Aug 2007
Pg. 288-291
|
The Lived Experience of Perimenopausal and Menopausal Women Undergoing Treatment with Bioidentical Hormones
Holt-Waldo NaRisa Y, Stephenson Kenna
|
Jul/Aug 2007
Pg. 292-296
|
Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 1: An Overview
Cabaleiro Joe
|
Jul/Aug 2007
Pg. 297-298
|
Book Review: The Rexall Story: A History of Genius and Neglect
Grajeda Betty Jo
|
Jul/Aug 2007
Pg. 300
|
Calculations
Stockton Shelly J
|
Jul/Aug 2007
Pg. 324
|
Fentanyl 50-mg/mL in 0.9% Sodium Chloride Solution
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 328
|
Ketoconazole 25-mg Liquid Suppository
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 329
|
The Politics of Hormone Replacement Therapy
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 278-281
|
Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations
Okeke Claudia C
|
Jul/Aug 2007
Pg. 302-305
|
Quality-control Analytical Methods: Logbooks and Documentation Forms
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 306-311
|
Basics of Compounding: The Responsibilities of Compounding Personnel in Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 2
Allen Loyd V Jr, Okeke Claudia C
|
Jul/Aug 2007
Pg. 314-323
|
Standard Operating Procedure: U.S. Food and Drug Administration Inspection--Releasing a Sample to the U.S. Food and Drug Administration
Kupiec Tom, Kemp Jesse
|
Jul/Aug 2007
Pg. 326-327
|
Mebeverine Hydrochloride 20% gel
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 330
|
Moxifloxacin in Dianeal 1.36% Peritoneal Dialysis Solution
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 331
|
Oseltamivir 12-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 332
|
Phenytoin Sodium 20-mg/mL Topical Suspension
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 333
|
Ribavirin 40-mg/mL Suspension
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 334
|
Sufentanil 50-mg/mL in 0.9% Sodium Chloride Solution
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 335
|
Temozolomide 10-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 336
|
Vehicle N Formulas
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 337
|
Statistical Analysis of Barrier Isolator/Glovebox Glove Failure
Park Young H, Pines E, Ofouku M, Cournoyer ME
|
Jul/Aug 2007
Pg. 338-346
|
Chemical Stability of Cyproheptadine Hydrochloride in an Oral Liquid Dosage Form
Gupta Vishnu D
|
Jul/Aug 2007
Pg. 347-348
|
PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 1
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 350-351
|
PreScription: Pharmacy Education: Is It Contemporary?
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 354
|
United States Pharmacopeia Convention Standards and Clinical Information for Compounded Medications Used in Veterinary Medicine
DeVeau Ian
|
Sep/Oct 2007
Pg. 357-362
|
Rabbit Medicine
Jordan Dinah G
|
Sep/Oct 2007
Pg. 364-374
|
The Whales: A Pharmacist's Story
Wills William R
|
Sep/Oct 2007
Pg. 376-383
|
Equine Cushing's Disease: A Clinical Update
Bliss George
|
Sep/Oct 2007
Pg. 384-388
|
Submitting Compelling Case Reports for Drug Therapy in Veterinary Patients
Davidson Gigi S
|
Sep/Oct 2007
Pg. 390-395
|
Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 2: Developing Essential Standard Operating Procedures
Cabaleiro Joe
|
Sep/Oct 2007
Pg. 397-398
|
Quality-Control Analytical Methods: A Discussion of United States Pharmacopeia Chapter <71> Sterility Tests
Kupiec Thomas C
|
Sep/Oct 2007
Pg. 400-403
|
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels
Allen Loyd V Jr, Okeke Claudia C
|
Sep/Oct 2007
Pg. 404-410
|
Calculations: Compounding for Veterinary Patients
Stockton Shelly J
|
Sep/Oct 2007
Pg. 412
|
Standard Operating Procedure: Complaint and Mishap Rectification
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 414-415
|
Acetaminophen 500-mg and Diphenhydramine Hydrochloride 25-mg Hot Therapy Packs
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 416
|
Acetylcysteine 200-mg/mL Oral Liquid
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 417
|
Acetylcysteine 200-mg Packets
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 418
|
Betamethasone Valerate 0.1% Topical Gel
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 419
|
Dexpanthenol 5% Gel-Cream
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 420
|
Diclofenac Sodium 75-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 421
|
Ergonovine Maleate 0.2-mg/mL Injection, Veterinary
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 422
|
Hydrocortisone 0.5% Ethanolic Gel
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 423
|
Neomycin 0.05% Topical Gel
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 424
|
Nondetergent Neutral Dry Skin Cream
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 425
|
Zinc Content of Commercial Diluents Widely Use in Drug Admixtures Prepared for Intravenous Infusion
Desai Narendra R, Shah Syed M, Koczone Julianna, Vencl-Joncic Maja, Sisto Christopher, Ludwig Stephen A
|
Sep/Oct 2007
Pg. 426-432
|
Isoniazid Release from Suppositories Compounded with Selected Bases
Hudson Kristofer C, Asbill C Scott, Webster Andrew A
|
Sep/Oct 2007
Pg. 433-437
|
PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 2
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 438-439
|
PreScription: Thoughts on Technology and Pharmacy
Allen Loyd V Jr
|
Nov/Dec 2007
Pg. 442
|
The Internet on Steroids: How Connected is Your Pharmacy?
Felkey Bill G
|
Nov/Dec 2007
Pg. 445-448
|
Achievement of USP Chapter <797> Compliance by a 35-Bed Rural Hospital: A Case Study
Peters Gregory F, McKeon Marghi R, Nerbun Richard G
|
Nov/Dec 2007
Pg. 450-470
|
The Internet and Its Websites: Your New Business Partner
Williams LaVonn A, Mehlhaff Deborah K
|
Nov/Dec 2007
Pg. 472-475
|
Proteins Used as Sweeteners
Li Xiaojian, Alexander Kenneth S
|
Nov/Dec 2007
Pg. 476-481
|
Soda Jerk
Mitchell Robert M
|
Nov/Dec 2007
Pg. 483-484
|
Quality-Control Analytical Methods: In-House Quality Control of Simple Compounds
Trusley Craig
|
Nov/Dec 2007
Pg. 487-490
|
Aloe Vera Gel
Allen Loyd V Jr
|
Nov/Dec 2007
Pg. 504
|
Breast Care Cream
Allen Loyd V Jr
|
Nov/Dec 2007
Pg. 505
|
Castor Oil and Trypsin Ointment
Allen Loyd V Jr
|
Nov/Dec 2007
Pg. 506
|
Topical Pain Relief: Assessment of Patient Satisfaction with a Novel Compound Containing at Least Ketoprofen
Zugerman Jessie Jean M, Reed Thomas C
|
Nov/Dec 2007
Pg. 514-519
|
Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration
Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
|
Nov/Dec 2007
Pg. 520-524
|
PostScription: The History of Pharmacy
Stroud Elaine C
|
Nov/Dec 2007
Pg. 526-527
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 4: Considerations in Selection and Use of Disinfectants and Antiseptics
Allen Loyd V Jr, Okeke Claudia C
|
Nov/Dec 2007
Pg. 492-499
|
Calculations: High-Technology Compounding and Investigational Dispensing
Webb Sheldon D, Stockton Shelly J
|
Nov/Dec 2007
Pg. 500-501
|
Standard Operating Procedure: Vial Crimper--Use, Care, Cleaning, and Maintenance
Allen Loyd V Jr
|
Nov/Dec 2007
Pg. 502-503
|
Chlorhexidine 2% Gel
Allen Loyd V Jr
|
Nov/Dec 2007
Pg. 507
|
Coal Tar 2% and Allantoin 2.5% Cream
Allen Loyd V Jr
|
Nov/Dec 2007
Pg. 508
|
Foscarnet 2.5% Topical Cream
Allen Loyd V Jr
|
Nov/Dec 2007
Pg. 509
|
Interferon alfa-2b Ophthalmic Solution
Allen Loyd V Jr
|
Nov/Dec 2007
Pg. 510
|
Lidocaine Hydrochloride 1.82% Buffered Injection
Allen Loyd V Jr
|
Nov/Dec 2007
Pg. 511
|
Miconazole 2% Oral Gel
Allen Loyd V Jr
|
Nov/Dec 2007
Pg. 512
|
Sodium Phenylbutyrate 200-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2007
Pg. 513
|
Return to Top |